Sherida E. Tollefsen

2.1k total citations
29 papers, 1.3k citations indexed

About

Sherida E. Tollefsen is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Sherida E. Tollefsen has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Molecular Biology and 11 papers in Surgery. Recurrent topics in Sherida E. Tollefsen's work include Growth Hormone and Insulin-like Growth Factors (11 papers), Pancreatic function and diabetes (10 papers) and Glycosylation and Glycoproteins Research (7 papers). Sherida E. Tollefsen is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (11 papers), Pancreatic function and diabetes (10 papers) and Glycosylation and Glycoproteins Research (7 papers). Sherida E. Tollefsen collaborates with scholars based in United States, Ireland and Norway. Sherida E. Tollefsen's co-authors include Rosalind Kornfeld, Patrick Tong, Stuart Kornfeld, Peter Rotwein, David R. Clemmons, Rosemarie Lajara, Katherine A. Thompson, Lori M. Laffel, Ruth S. Weinstock and Daniel J. Petersen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Sherida E. Tollefsen

28 papers receiving 1.3k citations

Peers

Sherida E. Tollefsen
Jeremy Turner United Kingdom
H. Arita Japan
Russell Marians United States
Najib Lamharzi United States
Lorin K. Johnson United States
H. Hoshi Japan
Rama Soundararajan United States
Jeremy Turner United Kingdom
Sherida E. Tollefsen
Citations per year, relative to Sherida E. Tollefsen Sherida E. Tollefsen (= 1×) peers Jeremy Turner

Countries citing papers authored by Sherida E. Tollefsen

Since Specialization
Citations

This map shows the geographic impact of Sherida E. Tollefsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherida E. Tollefsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherida E. Tollefsen more than expected).

Fields of papers citing papers by Sherida E. Tollefsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherida E. Tollefsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherida E. Tollefsen. The network helps show where Sherida E. Tollefsen may publish in the future.

Co-authorship network of co-authors of Sherida E. Tollefsen

This figure shows the co-authorship network connecting the top 25 collaborators of Sherida E. Tollefsen. A scholar is included among the top collaborators of Sherida E. Tollefsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherida E. Tollefsen. Sherida E. Tollefsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
ghormli, Laure El, Diane Uschner, Morey W. Haymond, et al.. (2023). Trajectories of eGFR and risk of albuminuria in youth with type 2 diabetes: results from the TODAY cohort study. Pediatric Nephrology. 38(12). 4137–4144. 2 indexed citations
2.
Higgins, Janine, Philip Zeitler, Kimberly L. Drews, et al.. (2022). ZnT8 autoantibody prevalence is low in youth with type 2 diabetes and associated with higher insulin sensitivity, lower insulin secretion, and lower disposition index. Journal of Clinical & Translational Endocrinology. 29. 100300–100300.
3.
Todd, Jennifer N., Jeffrey W. Kleinberger, Haichen Zhang, et al.. (2021). Monogenic Diabetes in Youth With Presumed Type 2 Diabetes: Results From the Progress in Diabetes Genetics in Youth (ProDiGY) Collaboration. Diabetes Care. 44(10). 2312–2319. 18 indexed citations
4.
Bjornstad, Petter, Laure El ghormli, Kara S. Hughan, et al.. (2021). Effects of Metabolic Factors, Race-Ethnicity, and Sex on the Development of Nephropathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study. Diabetes Care. 45(5). 1056–1064. 11 indexed citations
6.
Kleinberger, Jeffrey W., Kenneth C. Copeland, Rachelle Gandica, et al.. (2017). Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial. Genetics in Medicine. 20(6). 583–590. 70 indexed citations
7.
Tollefsen, Sherida E., et al.. (2002). Chemiluminescence response of granulocytes from elite athletes during recovery from one or two intense bouts of exercise. European Journal of Applied Physiology. 88(1-2). 20–28. 11 indexed citations
8.
Valenzano, Kenneth J., et al.. (1997). Biophysical and Biological Properties of Naturally Occurring High Molecular Weight Insulin-like Growth Factor II Variants. Journal of Biological Chemistry. 272(8). 4804–4813. 24 indexed citations
9.
Pearce, Simon H. S., C Wooding, Michael Davies, et al.. (1996). Calcium‐sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis. Clinical Endocrinology. 45(6). 675–680. 56 indexed citations
10.
Thompson, K.A., et al.. (1992). Low Prevalence of Autoantibodies to the Insulin-like Growth Factor I Receptor in Children with Short Stature. Pediatric Research. 32(4). 455–459. 2 indexed citations
11.
Tollefsen, Sherida E., et al.. (1991). Interaction of the .alpha..beta. dimers of the insulin-like growth factor I receptor is required for receptor autophosphorylation. Biochemistry. 30(1). 48–54. 12 indexed citations
12.
Tollefsen, Sherida E., et al.. (1991). Endogenous insulin-like growth factor (IGF) binding proteins cause IGF-1 resistance in cultured fibroblasts from a patient with short stature.. Journal of Clinical Investigation. 87(4). 1241–1250. 20 indexed citations
13.
Bier, Dennis M., et al.. (1990). Whole Body Nitrogen Kinetics and Their Relationship to Growth in Short Children Treated with Recombinant Human Growth Hormone. Pediatric Research. 28(4). 394–400. 9 indexed citations
14.
Tollefsen, Sherida E., et al.. (1989). Insulin-like Growth Factors (IGF) in Muscle Development. Journal of Biological Chemistry. 264(23). 13810–13817. 200 indexed citations
15.
Tollefsen, Sherida E. & Katherine A. Thompson. (1988). The structural basis for insulin-like growth factor I receptor high affinity binding.. Journal of Biological Chemistry. 263(31). 16267–16273. 37 indexed citations
16.
Tong, Patrick, Sherida E. Tollefsen, & Stuart Kornfeld. (1988). The cation-independent mannose 6-phosphate receptor binds insulin-like growth factor II.. Journal of Biological Chemistry. 263(6). 2585–2588. 165 indexed citations
17.
Tollefsen, Sherida E. & Rosalind Kornfeld. (1984). The B4 lectin from Vicia villosa seeds interacts with N-acetylgalactosamine residues on erythrocytes with blood group Cad specificity. Biochemical and Biophysical Research Communications. 123(3). 1099–1106. 17 indexed citations
18.
Tollefsen, Sherida E. & Rosalind Kornfeld. (1983). Isolation and characterization of lectins from Vicia villosa. Two distinct carbohydrate binding activities are present in seed extracts.. Journal of Biological Chemistry. 258(8). 5165–5171. 112 indexed citations
19.
Gavin, James R., et al.. (1982). Growth Hormone Receptors in Isolated Rat Adipocytes*. Endocrinology. 110(2). 637–643. 48 indexed citations
20.
Tollefsen, Sherida E., Edward R.B. McCabe, & Stephen I. Goodman. (1980). Neonatal Hyperammonemia. PEDIATRICS. 65(6). 1197–1198. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026